Evidence map›Paper›PMID 22539813›Full record

ArticleThe Journal of infectious diseases2012

PD-1-mediated attrition of polyfunctional memory CD8+ T cells in chronic toxoplasma infection.

Rajarshi Bhadra, Jason P Gigley, Imtiaz A Khan

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. T cell exhaustion in parasitic infections.Frontiers in immunology · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Effects ofFood and waterborne parasitology · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. NK Cells Negatively Regulate CD8 T Cells to Promote Immune Exhaustion and ChronicFrontiers in cellular and infection microbiology · 2020
    Article
  17. Review
  18. Review
  19. Toxoplasma: Immunity and Pathogenesis.Current clinical microbiology reports · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rajarshi BhadraDepartment of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC DC20037, USA.
Jason P Gigley
Imtiaz A Khan
George Washington University · US

Funding

LONG TERM IMMUNITY AGAINST TOXOPLASMOSISR01AI033325 · NIAID · LOUISIANA STATE UNIV HSC NEW ORLEANS · PI KHAN, IMTIAZ AHMED · 1998 to 2020
$6.2M
LONG TERM IMMUNITY AGAINST TOXOPLASMOSISR21AI033325 · NIAID · DARTMOUTH COLLEGE · PI KHAN, IMTIAZ AHMED · 1997 to 1997
–
TOXOPLASMA GONDII MEDIATED IMMUNOSUPPRESSIONR29AI033325 · NIAID · DARTMOUTH COLLEGE · PI KHAN, IMTIAZ AHMED · 1992 to 1996
–
NIAID NIH HHS AI-33325NIAID NIH HHS R01 AI033325
6 · The paper itself

Abstract

We reported earlier that during chronic toxoplasmosis CD8(+) T cells become functionally exhausted with concomitant PD-1 upregulation, leading to eventual host mortality. However, how immune exhaustion specifically mediates attrition of CD8 polyfunctionality, a hallmark of potent T-cell response, during persistent infections has not been addressed. In this study, we demonstrate that PD-1 is preferentially expressed on polyfunctional memory CD8(+) T cells, which renders them susceptible to apoptosis. In vitro blockade of the PD-1-PD-L1 pathway dramatically reduces apoptosis of polyfunctional and interferon γ(+)/granzyme B(-) memory but not effector CD8(+) T cells. In summary, the present report underscores the critical role of the PD-1-PD-L1 pathway in mediating attrition of this important CD8(+) T-cell subset and addresses the mechanistic basis of how αPD-L1 therapy reinvigorates polyfunctional CD8 response during chronic infections. The conclusions of this study can have profound immunotherapeutic implications in combating recrudescent toxoplasmosis as well other chronic infections.

Indexed as

AnimalsApoptosisApoptosis Regulatory ProteinsCD8-Positive T-LymphocytesChronic DiseaseFemaleGranzymesImmunologic MemoryInterferon-gammaMiceProgrammed Cell Death 1 ReceptorToxoplasmaToxoplasmosisUp-RegulationApoptosis Regulatory ProteinsGranzymesInterferon-gammaPdcd1 protein, mouseProgrammed Cell Death 1 Receptor

Identifiers

PMID22539813
PMCPMC3415930
OpenAlexW2120249273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.